Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2022 | Infectious toxicities in patients with multiple myeloma treated with bispecific antibodies

Joaquin Martinez-Lopez, MD, PhD, Complutense University of Madrid, Madrid, Spain, comments on the incidence of infectious toxicities in patients with multiple myeloma treated with bispecific antibodies, including febrile neutropenia, viral infection, and immunosuppression. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.